Todos to license Acumen Diagnostics’ PCR-based sepsis diagnostic test
The laboratory-developed test (LDT), dubbed AcuSept, is a host immune response test, designed to identify 19 mRNA biomarkers…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
29 Mar 23
The laboratory-developed test (LDT), dubbed AcuSept, is a host immune response test, designed to identify 19 mRNA biomarkers…
29 Mar 23
Acutis will develop the new genomic assay, based on its approved lab-developed tests, by combining SOPHiA DDM for…
29 Mar 23
Our report includes a comprehensive and in-depth analysis of the types and amount of microorganisms present, gut microbiome…
28 Mar 23
SpermX delivers reliable results to solve sexual assault crimes
28 Mar 23
The smallest disposable CMOS endoscope to receive clearance by the FDA
27 Mar 23
The FORESEE trial's objectives are to assess the effectiveness of the CNSide test in tracking the LM's reaction…
24 Mar 23
The study compared volume and pressure in HF patients who underwent CardioMEMS implantation with direct measurement of total…
24 Mar 23
The newly available diagnostic test detects active COVID-19 and/or flu infection, with results available in as few as…
23 Mar 23
Roche and Lilly will jointly support the development of Roche Diagnostics’ Elecsys Amyloid Plasma Panel that enables early…
22 Mar 23
The algorithm, dubbed Viz AAA, leverages artificial intelligence to automatically search for an abdominal aortic aneurysm (AAA) in…